In this work, DAXX is identified as a regulator of oncogenic lipogenesis through its interaction with SREBP1/2, leading to activating lipogenic gene expression programs and the promotion of cancer cell proliferation in vitro and tumor growth in vivo. Here, SREBF1 is linked to neoplasm.